Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01858883
Title Safety Study of INCB039110 in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Incyte Corporation
Indications

pancreatic adenocarcinoma

Advanced Solid Tumor

Therapies

Nab-paclitaxel

Filgrastim

Itacitinib

Gemcitabine

Age Groups: adult
Covered Countries USA


No variant requirements are available.